Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet

NCT03143712 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lakefront Biotherapeutics NV